Gene · 5898
Papers2,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From targeted therapy to a novel way: Immunogenic cell death in lung cancer. | Front Med (Lausanne) | 2022 | 36619616 | PubTator, text mining | PubMed |
| The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma. | Int J Mol Sci | 2022 | 36614082 | PubTator, text mining | PubMed |
| Filamin A in platelets: Bridging the (signaling) gap between the plasma membrane and the actin cytoskeleton. | Front Mol Biosci | 2022 | 36605989 | PubTator, text mining | PubMed |
| Freehand Juxtapedicular Screws Placed in the Apical Concavity of Adult Idiopathic Scoliosis Patients: Technique, Computed Tomography Confirmation, and Radiographic Results. | Neurospine | 2022 | 36597645 | PubTator, text mining | PubMed |
| Tele-education model for primary care providers to advance diabetes equity: Findings from Project ECHO Diabetes. | Front Endocrinol (Lausanne) | 2022 | 36589850 | PubTator, text mining | PubMed |
| Targeting Platelet Activation Pathways to Limit Tumour Progression: Current State of Affairs. | Pharmaceuticals (Basel) | 2022 | 36558983 | PubTator, text mining | PubMed |
| Aggregation of Genome-Wide Association Data from FinnGen and UK Biobank Replicates Multiple Risk Loci for Pregnancy Complications. | Genes (Basel) | 2022 | 36553520 | PubTator, text mining | PubMed |
| Lipid Polarization during Cytokinesis. | Cells | 2022 | 36552741 | PubTator, text mining | PubMed |
| Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer. | BMC Cancer | 2022 | 36522653 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues. | Cancer Inform | 2022 | 36507075 | PubTator, text mining | PubMed |
| Estimating Metastatic Risk of Pancreatic Ductal Adenocarcinoma at Single-Cell Resolution. | Int J Mol Sci | 2022 | 36499343 | PubTator, text mining | PubMed |
| Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects. | Cancers (Basel) | 2022 | 36497444 | PubTator, text mining | PubMed |
Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma. | Front Immunol | 2022 | 36483553 | PubTator, text mining | PubMed |
| Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker. | Front Immunol | 2022 | 36466919 | PubTator, text mining | PubMed |
| High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018-2019. | Open Forum Infect Dis | 2022 | 36438615 | PubTator, text mining | PubMed |
| Application of Peptides in Construction of Nonviral Vectors for Gene Delivery. | Nanomaterials (Basel) | 2022 | 36432361 | PubTator, text mining | PubMed |
| Discovering and Targeting Dynamic Drugging Pockets of Oncogenic Proteins: The Role of Magnesium in Conformational Changes of the G12D Mutated Kirsten Rat Sarcoma-Guanosine Diphosphate Complex. | Int J Mol Sci | 2022 | 36430338 | PubTator, text mining | PubMed |
| In Silico Study of the Acquired Resistance Caused by the Secondary Mutations of KRAS G12C Protein Using Long Time Molecular Dynamics Simulation and Markov State Model Analysis. | Int J Mol Sci | 2022 | 36430323 | PubTator, text mining | PubMed |
| The Potential of NORAD-PUMILIO-RALGAPB Regulatory Axis as a Biomarker in Breast Cancer. | Noncoding RNA | 2022 | 36412911 | PubTator, text mining | PubMed |
| MSC-EV therapy for bone/cartilage diseases. | Bone Rep | 2022 | 36389627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5898/papers?page=14